ElAbd H, Pesesky M, Innocenti G, Chung BK, Mahdy AKH, Kriukova V, Kulsvehagen L, Strobbe D, Stühler C, Mayr G, May DH, Prinzensteiner M, Steiert TA, Tran F, Hadjihannas MV, Günther R, Rosati E, Mucha S, Lieb W, Ziemann M, Dempfle A, Braun F, Folseraas T, Hov JR, Melum E et al. (2025)
T and B cell responses against Epstein-Barr virus in primary sclerosing cholangitis
Nat Med, 31 (7), 2306-2316
DOI 10.1038/s41591-025-03692-w, PubMed 40500415

Holmer M, Ingre M, Färkkilä M, Ponsioen C, Mol B, Schramm C, Folseraas T, Wiencke K, Cazzagon N, Catanzaro E, Molinaro A, Nilsson E, Vessby J, Kechagias S, Nyhlin N, Werner M, Bergquist A (2025)
Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study
Hepatology (in press)
DOI 10.1097/HEP.0000000000001351, PubMed 40238209

Singh Y, Eaton JE, Venkatesh SK, Welle CL, Smith B, Faghani S, Vesterhus M, Karlsen TH, Jorgensen KK, Folseraas T, Petrovic K, Negard A, Bjoerk I, Abildgaard A, Gulamhusein AF, Jhaveri K, Gores GJ, Ilyas SI, Taner T, Heimbach JK, Diwan TS, LaRusso NF, Lazaridis KN, Erickson BJ (2025)
Deep learning analysis of MRI accurately detects early-stage perihilar cholangiocarcinoma in patients with primary sclerosing cholangitis
Hepatology (in press)
DOI 10.1097/HEP.0000000000001314, PubMed 40112296